Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
None listed
Sponsors
Dabur Research and Development Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male or female aged more than and equal to 30 years and less than and equal to 70 years 2) Body mass index between 18 Kgperm2 and 35 Kgperm2 3)Total cholesterol level between 200 and 280 mgperdL andor LDL-C between 130 mgperdL and 190 mgperdL TGless5percentage) 3)The intervention strategy does not require a pharmacological lipid-lowering intervention, according to any ICMR guidelines 4)Subjects who can communicate, make themselves understood and comply with the requirements of the study 5)Subjects who agree to participate in the study and have dated and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1) Ongoing lipid lowering therapy 2) Ongoing drug treatment that has not been stabilized for at least 3 months 3) Known current thyroid gastrointestinal or hepatobiliary disease(including liver transaminasesmorethanequalto3ULN) and any muscular disorders (even subclinicalincluding serum CPKmorethanequal to 3ULN) 4)Current or previous alcohol abuse5)Pregnancy and breastfeeding 6) Known previous intolerance to RYR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of LDL-C and LipidsTimepoint: up to 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in clinical symptomsTimepoint: up to 12 weeks | — |
Countries
India
Contacts
Public ContactDr Dipak Ranjan Das
Dabur Research and Development Centre Dabur India limited
Outcome results
None listed